首頁 > 市場調查報告書 > 製藥

個人化醫學

市場調查報告書

商品編碼

1274332

個性化醫療生物標誌物的全球市場研究報告——2023-2030 年行業分析、規模、份額、增長、趨勢和預測

Global Personalized Medicine Biomarkers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年05月01日 | 出版商:

Value Market Research | 英文 125 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球對個性化醫療生物標誌物市場的需求將從2022年的249.2億美元增長到2030年的近1754.6億美元，2023-2030年研究期間複合年增長率為27.63%，預計將達到市場規模。

個性化藥物生物標誌物是利用生物標誌物為患者開發個性化藥物。它支持治療政策決策、治療結果的改善以及為患□□者建立安全的治療方法。它也是預後性的，因此可用於預測健康問題的發生和選擇劑量。生物標誌物可以幫助更早發現疾病、提高患者生存率並降低治療成本。

市場動態：

由於全球慢性病患病率上升，個性化醫療生物標誌物市場正在蓬勃發展。診斷和檢測慢性病的進步以及對個性化醫療的需求不斷增加，都促進了這一市場的增長。人們越來越意識到預後預測的重要性，這推動了對個性化醫學生物標誌物市場的需求。此外，個性化醫學生物標誌物的各種優勢，如早期發現疾病和降低治療成本，正在推動這一市場的需求。此外，生物標誌物開發的持續進展有望在預測期內推動個性化醫療生物標誌物的市場增長。

這份研究報告解釋了波特的五力模型、市場吸引力分析和價值鏈分析。這些工具可幫助您清楚地了解您的行業結構並評估您在全球範圍內的競爭吸引力。此外，這些工具還對全球個性化醫療生物標誌物市場的各個細分市場進行全面評估。個性化醫療生物標誌物行業的發展和趨勢為這項研究提供了一種整體方法。

市場細分：

在本節中，我們將按國家和地區提供詳細的細分數據，確定產品和服務的目標受眾，並支持未來的商機。

使用

早期檢測/篩查
診斷
治療選擇
監控

根據指示

腫瘤學（類型、循環生物標誌物）
神經學
糖尿病
自身免疫性疾病
循環區
其他

按地區分析：

本部分涵蓋區域展望，重點介紹北美、歐洲、亞太地區、拉丁美洲、中東和非洲對個性化醫療生物標誌物市場的當前和未來需求。此外，我們還關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況和全球競爭格局的詳細視圖。個性化醫學生物標誌物市場的主要參與者是美國控股實驗室公司、Quest Diagnostics Incorporated、Agilent Technologies Inc、Genome Medical Inc、Coriell Life Sciences.、Thermo Fisher Scientific Inc.、NeoGenomics Laboratories、Foundation Medicine Inc、Illumina Inc、Guardant Health . 本節概述了競爭格局，包括各種戰略發展，例如主要併購、未來能力、合作夥伴關係、財務概覽、合作、新產品開發和新產品發布。

內容

第一章前言

本報告的內容
- 目的
- 目標受眾
- 獨特的銷售主張 (USP) 及其提供的內容
調查範圍
調查方法
- 市場調研過程
- 市場研究方法

第 2 章執行摘要

市場亮點
全球市場概況

第 3 章個性化醫療生物標誌物 - 行業分析

簡介 - 市場動態
市場驅動力
市場製約因素
商機
行業趨勢
波特的五力分析
市場吸引力分析
- 市場吸引力分析：按應用
- 按市場進行的吸引力分析：按指示
- 市場吸引力分析：按地區

第四章價值鏈分析

價值鏈分析
原材料分析
- 原材料清單
- 原材料製造商列表
- 主要原材料價格走勢
潛在買家名單
營銷渠道
- 直接營銷
- 間接營銷
- 營銷渠道趨勢

第 5 章 COVID-19 爆發的影響分析

第 6 章個性化醫療生物標誌物的全球市場分析：按應用

總結：按應用
實際數據和預測數據
分析：按應用
早期檢測/篩查
診斷
治療選擇
監控

第 7 章個性化醫療生物標誌物的全球市場分析：按適應症分類

適應症概覽
歷史和預測數據
適應症分析
腫瘤學（類型、循環生物標誌物）
神經學
糖尿病
自身免疫性疾病
循環區
其他

第 8 章個性化醫療生物標誌物的全球市場分析：按地區

區域展望
簡介
北美銷售分析
- 概覽、歷史和預測銷售分析
- 北美各部門的銷售分析
- 北美銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史和預測銷售分析
- 按細分市場進行的歐洲銷售分析
- 按國家/地區劃分的歐洲銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 意大利銷售分析
- 俄羅斯銷售分析
- 其他歐洲銷售分析
亞太地區銷售分析
- 概覽、歷史和未來銷售分析
- 亞太地區各部門的銷售分析
- 亞太國家/地區銷售分析
- 在中國的銷售分析
- 印度銷售分析
- 日本的銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 其他亞太地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史和未來銷售分析
- 拉丁美洲各部門的銷售分析
- 拉丁美洲國家/地區的銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利的銷售分析
- 其他拉丁美洲銷售分析
中東和非洲銷售分析
- 概覽、歷史和未來銷售分析
- 中東/非洲地區的銷售分析
- 中東和非洲國家/地區的銷售分析
- 沙特阿拉伯銷售分析
- 阿聯酋銷售分析
- 以色列銷售分析
- 南非銷售分析
- 其他中東和非洲銷售分析

第9章個性化醫療生物標誌物公司的競爭狀況

個性化醫療生物標誌物市場競爭
夥伴關係、合作、協議
併購
新產品發布
其他發展

第十章公司簡介

頂級公司的市場份額分析
市場集中度
美國控股實驗室公司
- 公司簡介
- 企業收入
- 產品介紹
- 近期發展狀況
奎斯特診斷公司
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
安捷倫科技公司
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
基因組醫療公司
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
Coriell 生命科學。
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
Thermo Fisher Scientific Inc.
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
新基因組學實驗室
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
Foundation Medicine Inc.
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
因美納公司
- 公司簡介
- 企業收入
- 產品信息
- 近期發展狀況
守護健康
- 公司簡介
- 企業收入
- 產品信息
- 近期趨勢

注意：公司簡介中的財務細節和近期發展基於可用信息，可能不包括私營公司。

簡介目錄圖表

Product Code: VMR112110341

The global demand for Personalized Medicine Biomarkers Market is presumed to reach the market size of nearly USD 175.46 BN by 2030 from USD 24.92 BN in 2022 with a CAGR of 27.63% under the study period 2023 - 2030.

Personalised medicine biomarkers are the use of biomarkers for developing personalised medicines for patients. It assists in making treatment decisions, improving treatment outcomes and creating safe therapies for patients. It also helps predict the occurrence of health issues and dose selection due to their prognostic utility. Biomarker helps in the early detection of diseases, increase the chance of patient survival, and reduce treatment cost.

Market Dynamics:

The personalised medicine biomarkers market growth is witnessing an upward trend due to the rising prevalence of chronic diseases all over the globe. The advancement in diagnosis and detection of chronic diseases, coupled with the growing demand for personalised medicines, are contributing to the growth of this market. Increasing awareness regarding the importance of predicting prognosis is surging the demand for the personalised medicine biomarkers market. In addition, different advantages of personalised medicine biomarkers, such as early detection of diseases and reduction in the cost of treatment, are propelling the demand for this market. Furthermore, continuous advancement in the development of biomarkers is expected to boost the growth of personalised medicine biomarkers in the market over the forecast period.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of personalized medicine biomarkers. The growth and trends of personalized medicine biomarkers industry provide a holistic approach to this study.

Market Segmentation:

This section of the personalized medicine biomarkers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Early Detection/Screening
Diagnosis
Treatment Selection
Monitoring

By Indication

Oncology (Type, Circulating Biomarkers)
Neurology
Diabetes
Autoimmune Diseases
Cardiology
Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Personalized Medicine Biomarkers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the personalized medicine biomarkers market include Laboratory Corporation of America Holding, Quest Diagnostics Incorporated, Agilent Technologies Inc., Genome Medical Inc., Coriell Life Sciences., Thermo Fisher Scientific Inc., NeoGenomics Laboratories, Foundation Medicine Inc, Illumina Inc., Guardant Health. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . PERSONALIZED MEDICINE BIOMARKERS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Indication
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Early Detection/Screening Historic and Forecast Sales by Regions
6.5 Diagnosis Historic and Forecast Sales by Regions
6.6 Treatment Selection Historic and Forecast Sales by Regions
6.7 Monitoring Historic and Forecast Sales by Regions

7 . GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET ANALYSIS BY INDICATION

7.1 Overview by Indication
7.2 Historical and Forecast Data
7.3 Analysis by Indication
7.4 Oncology (Type, Circulating Biomarkers) Historic and Forecast Sales by Regions
7.5 Neurology Historic and Forecast Sales by Regions
7.6 Diabetes Historic and Forecast Sales by Regions
7.7 Autoimmune Diseases Historic and Forecast Sales by Regions
7.8 Cardiology Historic and Forecast Sales by Regions
7.9 Others Historic and Forecast Sales by Regions

8 . GLOBAL PERSONALIZED MEDICINE BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE PERSONALIZED MEDICINE BIOMARKERS COMPANIES

9.1. Personalized Medicine Biomarkers Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF PERSONALIZED MEDICINE BIOMARKERS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Laboratory Corporation of America Holding
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Quest Diagnostics Incorporated
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Agilent Technologies Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Genome Medical Inc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Coriell Life Sciences.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Thermo Fisher Scientific Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. NeoGenomics Laboratories
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Foundation Medicine Inc
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Illumina Inc.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Guardant Health
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表